+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 55Years +
All Genders
Healthy Volunteers
ID07786116

Met-Pro Study Investigating Methane-Producing Gut Microbes and Their Role in Parkinsons Disease and Related Neurological Conditions

Led by University of Cambridge · Updated on 2026-08-25

215

Participants Needed

1

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the role of methane-producing microbes in the gut and their link to Parkinsons disease PD and related neurological conditions like dementia and mild cognitive impairment. The study aims to understand how intestinal methanogen overgrowth IMO, detected by breath methane levels, is associated with gut symptoms, motor and cognitive problems, and disease progression. This includes exploring inflammation and gut-brain interactions among people with PD, high risk of PD, cognitive impairment, and healthy controls. The study has two parts an observational study following 200 participants from four groups over 18 months with two visits, assessing breath methane, stool microbiology, blood inflammation markers, and neurological and cognitive tests. A smaller experimental study will involve 15 participants with PD and high methane levels taking a daily probiotic supplement Limosilactobacillus reuteri for 18 months to evaluate its effect on methane production, gut microbes, inflammation, and clinical symptoms. Participants will undergo breath tests, stool and blood sample collection, and clinical assessments including neurological exams and questionnaires at baseline and after 18 months. The study will measure changes in breath methane, gut microbes, inflammation, motor and cognitive function, and disease progression. The probiotic groups outcomes will include methane levels and inflammatory markers. The total participation time is about 18 months, with close monitoring of symptoms and biological markers to explore methanes potential as a biomarker and therapeutic target.

CONDITIONS

Brief Title

The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions

Research Team

M

Marta Camacho, Dr.

C

Caroline Williams-Gray, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here